{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T20:24:54Z","timestamp":1768076694617,"version":"3.49.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T00:00:00Z","timestamp":1753056000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T00:00:00Z","timestamp":1753056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82060236"],"award-info":[{"award-number":["82060236"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82460254"],"award-info":[{"award-number":["82460254"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Natural Science Foundation of Guangxi Province","award":["Natural Science Foundation of Guangxi Province (CN)"],"award-info":[{"award-number":["Natural Science Foundation of Guangxi Province (CN)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-10750-3","type":"journal-article","created":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T09:58:16Z","timestamp":1753091896000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The characteristic change of autoimmune encephalitis after the COVID-19 epidemic in Guangxi, China"],"prefix":"10.1038","volume":"15","author":[{"given":"Xianting","family":"Que","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manli","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ailing","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danli","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanlan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziqun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanzhen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yishuang","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,21]]},"reference":[{"issue":"3","key":"10750_CR1","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/tmi.13383","volume":"25","author":"TP Velavan","year":"2020","unstructured":"Velavan, T. P. & Meyer, C. G. The COVID-19 epidemic. Trop. Med. Int. Health. 25 (3), 278\u2013280 (2020).","journal-title":"Trop. Med. Int. Health"},{"key":"10750_CR2","doi-asserted-by":"crossref","unstructured":"Davis, H. E. et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 38, 101019 (2021).","DOI":"10.1016\/j.eclinm.2021.101019"},{"key":"10750_CR3","doi-asserted-by":"crossref","unstructured":"Nasserie, T., Hittle, M. & Goodman, S. N. Assessment of the frequency and variety of persistent symptoms among patients with COVID-19: A systematic review. JAMA Netw. Open. 4 (5), e2111417 (2021).","DOI":"10.1001\/jamanetworkopen.2021.11417"},{"issue":"4","key":"10750_CR4","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","volume":"15","author":"F Graus","year":"2016","unstructured":"Graus, F. et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 15 (4), 391\u2013404 (2016).","journal-title":"Lancet Neurol."},{"key":"10750_CR5","doi-asserted-by":"crossref","unstructured":"Sanchez-Larsen, A. et al.  Anti-NMDA-R encephalitis post-COVID-19: case report and proposed physiopathologic mechanism. Neurologia (Barcelona Spain) (2022).","DOI":"10.1016\/j.nrleng.2022.09.002"},{"key":"10750_CR6","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.1111\/ene.14913","volume":"28","author":"I Siow","year":"2021","unstructured":"Siow, I. et al. Encephalitis as a neurological complication of COVID-19: A systematic review and meta\u2010analysis of incidence, outcomes, and predictors. Eur. J. Neurol. 28, 3491\u20133502. https:\/\/doi.org\/10.1111\/ene.14913 (2021).","journal-title":"Eur. J. Neurol."},{"key":"10750_CR7","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/bjh.16794","volume":"190","author":"G Lazarian","year":"2020","unstructured":"Lazarian, G. et al. Autoimmune haemolytic anaemia associated with COVID-19 infection. Br. J. Haematol. 190, 29\u201331 (2020).","journal-title":"Br. J. Haematol."},{"key":"10750_CR8","doi-asserted-by":"crossref","unstructured":"Zhao, H. et al. Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2 infection: Causality or coincidence? Lancet Neurol. 19, 383 (2020).","DOI":"10.1016\/S1474-4422(20)30109-5"},{"key":"10750_CR9","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.1111\/ene.14913","volume":"28","author":"I Siow","year":"2021","unstructured":"Siow, I. et al. Encephalitis as a neurological complication of COVID-19: A systematic review and meta\u2010analysis of incidence, outcomes, and predictors. Eur. J. Neurol. 28, 3491\u20133502 (2021).","journal-title":"Eur. J. Neurol."},{"issue":"1","key":"10750_CR10","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/jmv.26207","volume":"93","author":"RK Garg","year":"2021","unstructured":"Garg, R. K., Paliwal, V. K. & Gupta, A. Encephalopathy in patients with COVID-19: A review. J. Med. Virol. 93 (1), 206\u2013222 (2021).","journal-title":"J. Med. Virol."},{"key":"10750_CR11","doi-asserted-by":"publisher","first-page":"e34658","DOI":"10.7759\/cureus.34658","volume":"15","author":"P Saffari","year":"2023","unstructured":"Saffari, P. et al. A Sharp rise in autoimmune encephalitis in the COVID-19 era: A case series. Cureus 15, e34658. https:\/\/doi.org\/10.7759\/cureus.34658 (2023).","journal-title":"Cureus"},{"key":"10750_CR12","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1136\/jnnp-2020-325300","volume":"92","author":"H Abboud","year":"2021","unstructured":"Abboud, H. et al. Autoimmune encephalitis: Proposed best practice recommendations for diagnosis and acute management. J. Neurol. Neurosurg. Psychiatry. 92, 757\u2013768 (2021).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10750_CR13","doi-asserted-by":"publisher","unstructured":"Callaway, E. COVID\u2019s future: Mini-waves rather than seasonal surges. Nature. 617 (7960), 229\u2013230. https:\/\/doi.org\/10.1038\/d41586-023-01437-8 (2023).","DOI":"10.1038\/d41586-023-01437-8"},{"key":"10750_CR14","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1056\/NEJMc2008597","volume":"382","author":"J Helms","year":"2020","unstructured":"Helms, J. et al. Neurologic features in severe SARS-CoV-2 infection. N. Engl. J. Med. 382, 2268\u20132270 (2020).","journal-title":"N. Engl. J. Med."},{"key":"10750_CR15","doi-asserted-by":"publisher","unstructured":"Larvie, M., Lev, M. H. & Hess, C. P. More on neurologic features in severe SARS-CoV-2 infection. N. Engl. J. Med.. https:\/\/doi.org\/10.1056\/NEJMc2015132 (2020).","DOI":"10.1056\/NEJMc2015132"},{"key":"10750_CR16","doi-asserted-by":"publisher","first-page":"3484","DOI":"10.1016\/j.neuron.2022.10.006","volume":"110","author":"M Monje","year":"2022","unstructured":"Monje, M. & Iwasaki, A. The neurobiology of long COVID. Neuron 110, 3484\u20133496 (2022).","journal-title":"Neuron"},{"key":"10750_CR17","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.3390\/vaccines11071225","volume":"11","author":"A Stoian","year":"2023","unstructured":"Stoian, A. et al. The occurrence of acute disseminated encephalomyelitis in SARS-CoV-2 infection\/vaccination: Our experience and a systematic review of the literature. Vaccines 11, 1225 (2023).","journal-title":"Vaccines"},{"key":"10750_CR18","doi-asserted-by":"publisher","first-page":"774","DOI":"10.3390\/biomedicines10040774","volume":"10","author":"A Stoian","year":"2022","unstructured":"Stoian, A. et al. Autoimmune encephalitis in COVID-19 infection: Our experience and systematic review of the literature. Biomedicines 10, 774 (2022).","journal-title":"Biomedicines"},{"key":"10750_CR19","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.nrleng.2020.07.012","volume":"35","author":"MJ Abenza-Abild\u00faa","year":"2020","unstructured":"Abenza-Abild\u00faa, M. J. et al. Neurological complications in critical patients with COVID-19. Neurolog\u00eda (English Edition). 35, 621\u2013627 (2020).","journal-title":"Neurolog\u00eda (English Edition)"},{"key":"10750_CR20","doi-asserted-by":"crossref","unstructured":"Karnik, M. et al. A review on SARS-CoV-2-induced neuroinflammation, neurodevelopmental complications, and recent updates on the vaccine development. Mol. Neurobiol. 58, 4535 (2021).","DOI":"10.1007\/s12035-021-02399-6"},{"key":"10750_CR21","doi-asserted-by":"crossref","unstructured":"Jha, N. K. et al. Evidence of coronavirus (CoV) pathogenesis and emerging pathogen SARS-CoV-2 in the nervous system: A review on neurological impairments and manifestations. J. Mol. Neurosci. 2192\u20132209 (2021).","DOI":"10.1007\/s12031-020-01767-6"},{"key":"10750_CR22","doi-asserted-by":"publisher","first-page":"105131","DOI":"10.1016\/j.nbd.2020.105131","volume":"146","author":"TP Buzhdygan","year":"2020","unstructured":"Buzhdygan, T. P. et al. The SARS-CoV-2 Spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood\u2013brain barrier. Neurobiol. Dis. 146, 105131 (2020).","journal-title":"Neurobiol. Dis."},{"key":"10750_CR23","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1007\/s10787-021-00847-2","volume":"29","author":"A Vitiello","year":"2021","unstructured":"Vitiello, A., Ferrara, F., Troiano, V. & La Porta, R. COVID-19 vaccines and decreased transmission of SARS-CoV-2. Inflammopharmacology 29, 1357\u20131360. https:\/\/doi.org\/10.1007\/s10787-021-00847-2 (2021).","journal-title":"Inflammopharmacology"},{"key":"10750_CR24","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.1111\/1462-2920.15549","volume":"23","author":"H Br\u00fcssow","year":"2021","unstructured":"Br\u00fcssow, H. COVID-19: Vaccination problems. Environ. Microbiol. 23, 2878\u20132890. https:\/\/doi.org\/10.1111\/1462-2920.15549 (2021).","journal-title":"Environ. Microbiol."},{"key":"10750_CR25","doi-asserted-by":"crossref","unstructured":"Baud, D. et al. Real estimates of mortality following COVID-19 infection. Lancet. Infect. Dis. 20 (7), 773 (2020).","DOI":"10.1016\/S1473-3099(20)30195-X"},{"key":"10750_CR26","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.nrl.2020.07.014","volume":"35","author":"MJ Abenza-Abild\u00faa","year":"2020","unstructured":"Abenza-Abild\u00faa, M. J. et al. Neurological complications in critical patients with COVID-19. Neurologia 35, 621\u2013627. https:\/\/doi.org\/10.1016\/j.nrl.2020.07.014 (2020).","journal-title":"Neurologia"},{"key":"10750_CR27","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/s41586-022-04462-1","volume":"603","author":"R Suzuki","year":"2022","unstructured":"Suzuki, R. et al. Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant. Nature 603, 700\u2013705 (2022).","journal-title":"Nature"},{"key":"10750_CR28","doi-asserted-by":"crossref","unstructured":"Fan, Y. et al. SARS-CoV-2 Omicron variant: recent progress and future perspectives. Signal Transduct. Target. Ther 7 (1),\u2009141 (2022).","DOI":"10.1038\/s41392-022-00997-x"},{"key":"10750_CR29","doi-asserted-by":"publisher","first-page":"e13101","DOI":"10.1111\/sji.13101","volume":"94","author":"MG Danieli","year":"2021","unstructured":"Danieli, M. G. et al. Intravenous immunoglobulin as an important adjunct in the prevention and therapy of coronavirus 2019 disease. Scand. J. Immunol. 94, e13101. https:\/\/doi.org\/10.1111\/sji.13101 (2021).","journal-title":"Scand. J. Immunol."},{"key":"10750_CR30","doi-asserted-by":"publisher","first-page":"823","DOI":"10.2147\/jir.S271768","volume":"13","author":"I Biswas","year":"2020","unstructured":"Biswas, I. & Khan, G. A. Coagulation disorders in COVID-19: Role of toll-like receptors. J. Inflamm. Res. 13, 823\u2013828. https:\/\/doi.org\/10.2147\/jir.S271768 (2020).","journal-title":"J. Inflamm. Res."},{"key":"10750_CR31","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.3389\/fimmu.2018.01299","volume":"9","author":"Y Guo","year":"2018","unstructured":"Guo, Y., Tian, X., Wang, X. & Xiao, Z. Adverse effects of Immunoglobulin therapy. Front. Immunol. 9, 1299. https:\/\/doi.org\/10.3389\/fimmu.2018.01299 (2018).","journal-title":"Front. Immunol."},{"key":"10750_CR32","doi-asserted-by":"publisher","first-page":"3104","DOI":"10.1093\/brain\/awaa240","volume":"143","author":"RW Paterson","year":"2020","unstructured":"Paterson, R. W. et al. The emerging spectrum of COVID-19 neurology: Clinical, radiological and laboratory findings. Brain J. Neurol. 143, 3104\u20133120. https:\/\/doi.org\/10.1093\/brain\/awaa240 (2020).","journal-title":"Brain J. Neurol."},{"key":"10750_CR33","doi-asserted-by":"publisher","first-page":"3","DOI":"10.47936\/encephalitis.2023.00171","volume":"4","author":"A Sawalha","year":"2023","unstructured":"Sawalha, A., Alkilani, H. & Abdelaziz, R. The association between autoimmune encephalitis mediated by n-methyl--aspartate receptor autoantibodies and covid-19: A systematic review. Encephalitis 4, 3\u201310 (2023).","journal-title":"Encephalitis"},{"key":"10750_CR34","doi-asserted-by":"publisher","unstructured":"Vences, M. et al. Post-vaccinal encephalitis with early relapse after BNT162b2 (COMIRNATY) COVID-19 vaccine: A case report. Vaccines 10 https:\/\/doi.org\/10.3390\/vaccines10071065 (2022).","DOI":"10.3390\/vaccines10071065"},{"key":"10750_CR35","doi-asserted-by":"publisher","first-page":"104495","DOI":"10.1016\/j.msard.2022.104495","volume":"70","author":"X Liu","year":"2023","unstructured":"Liu, X. et al. Safety of inactivated COVID-19 vaccines in autoimmune encephalitis: A real-world cross-sectional survey. Mult Scler. Relat. Disord. 70, 104495. https:\/\/doi.org\/10.1016\/j.msard.2022.104495 (2023).","journal-title":"Mult Scler. Relat. Disord"},{"key":"10750_CR36","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1111\/j.1468-1331.2010.03180.x","volume":"18","author":"JP Camdessanch\u00e9","year":"2011","unstructured":"Camdessanch\u00e9, J. P. et al. Brain immunohistopathological study in a patient with anti-NMDAR encephalitis. Eur. J. Neurol. 18, 929\u2013931. https:\/\/doi.org\/10.1111\/j.1468-1331.2010.03180.x (2011).","journal-title":"Eur. J. Neurol."},{"key":"10750_CR37","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/s12974-021-02293-x","volume":"18","author":"V Vasilevska","year":"2021","unstructured":"Vasilevska, V. et al. Molecular mimicry of NMDA receptors May contribute to neuropsychiatric symptoms in severe COVID-19 cases. J. Neuroinflamm. 18, 245. https:\/\/doi.org\/10.1186\/s12974-021-02293-x (2021).","journal-title":"J. Neuroinflamm."},{"key":"10750_CR38","doi-asserted-by":"publisher","first-page":"e13473","DOI":"10.1111\/apha.13473","volume":"229","author":"L Steardo","year":"2020","unstructured":"Steardo, L., Steardo Jr, L., Zorec, R. & Verkhratsky, A. Neuroinfection May contribute to pathophysiology and clinical manifestations of COVID-19. Acta Physiol. (Oxford England). 229, e13473 (2020).","journal-title":"Acta Physiol. (Oxford England)"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10750-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10750-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10750-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T16:22:26Z","timestamp":1757262146000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10750-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,21]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10750"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-10750-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,21]]},"assertion":[{"value":"22 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the First Affiliated Hospital of Guangxi Medical University (2024-E233-01). We had complied with the Declaration of Helsinki Ethical Principles for medical research involving human subjects. Written informed consents was obtained from all the patients enrolled in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and informed consent"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26400"}}